Literature DB >> 9202073

Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing.

R M Hershberg1, P E Framson, D H Cho, L Y Lee, S Kovats, J Beitz, J S Blum, G T Nepom.   

Abstract

Intestinal epithelial cells express a low level of HLA class II molecules constitutively, with elevated levels seen in the setting of mucosal inflammation including inflammatory bowel disease. The ability of intestinal epithelial cells to act as antigen presenting cells for alphabeta CD4(+) T lymphocytes was examined through a molecular analysis of the HLA class II antigen processing pathway. We have shown that intestinal epithelial cells contain abundant constitutive levels of the cathepsin proteases proven to function in HLA class II mediated antigen presentation. Activation of these cells by gamma-IFN induced the expression of invariant chain and HLA-DM alphabeta, thus facilitating the formation of compact, SDS-stable HLA- DR alphabeta heterodimers. Using HLA-DR-restricted T cells and retroviral mediated gene transfer of HLA-DR alleles into the intestinal epithelial cell lines HT-29 and T84, we demonstrated efficient antigen processing and presentation to CD4(+) T lymphocytes in the presence of the proinflammatory cytokine gamma-IFN. The class II processing pathway and presentation in the presence of gamma-IFN was indistinguishable from that observed with a conventional antigen presenting cell. Antigen processing also occurred in intestinal epithelial cells in the absence of gamma-IFN, and in contrast to that seen after stimulation with gamma-IFN, required high concentration of antigen and was not inhibited by the protease inhibitor leupeptin. These data suggest the use of two distinct pathways of HLA class II antigen processing in enterocytes with differential immunomodulatory properties in the presence or absence of mucosal inflammation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202073      PMCID: PMC508181          DOI: 10.1172/JCI119514

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  55 in total

1.  Cathepsin D is membrane-associated in macrophage endosomes.

Authors:  S Diment; M S Leech; P D Stahl
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

2.  Nonimmune human cells can express MHC class II antigens in the absence of invariant chain--an immunohistological study on normal and chronically inflamed small intestine.

Authors:  F Momburg; K Koretz; A Von Herbay; P Möller
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

3.  HLA-DQ molecules form alpha-beta heterodimers of mixed allotype.

Authors:  W W Kwok; D Schwarz; B S Nepom; R A Hock; P S Thurtle; G T Nepom
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

4.  A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus.

Authors:  O Cohen-Haguenauer; E Robbins; C Massart; M Busson; I Deschamps; J Hors; J M Lalouel; J Dausset; D Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  HLA-DQ beta chain DNA restriction fragments can differentiate between healthy and narcoleptic individuals with HLA-DR2.

Authors:  H Inoko; A Ando; K Tsuji; K Matsuki; T Juji; Y Honda
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

6.  A group-specific inhibitor of lysosomal cysteine proteinases selectively inhibits both proteolytic degradation and presentation of the antigen dinitrophenyl-poly-L-lysine by guinea pig accessory cells to T cells.

Authors:  S Buus; O Werdelin
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

7.  Antigen presentation by epithelial cells of the rat small intestine. I. Kinetics, antigen specificity and blocking by anti-Ia antisera.

Authors:  P W Bland; L G Warren
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

8.  The effect of gluten on HLA-DR in the small intestinal epithelium of patients with coeliac disease.

Authors:  P J Ciclitira; J M Nelufer; H J Ellis; D J Evans
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

9.  HLA-DR4 in insulin-dependent diabetic parents and their diabetic offspring: a clue to dominant inheritance.

Authors:  M J MacDonald; J Gottschall; J B Hunter; K L Winter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

10.  Evidence for function of Ia molecules on gut epithelial cells in man.

Authors:  L Mayer; R Shlien
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  57 in total

1.  Ligation of intestinal epithelial CD1d induces bioactive IL-10: critical role of the cytoplasmic tail in autocrine signaling.

Authors:  S P Colgan; R M Hershberg; G T Furuta; R S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 2.  Diversity in MHC class II antigen presentation.

Authors:  John H Robinson; Alexei A Delvig
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

Review 3.  Enterocytes: active cells in tolerance to food and microbial antigens in the gut.

Authors:  N Miron; V Cristea
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

4.  Activation antigens on colonic T cells in inflammatory bowel disease: effects of IL-10.

Authors:  E C Ebert; V Mehta; K M Das
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

5.  Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile.

Authors:  Peter P Tagkalidis; Peter R Gibson; Prithi S Bhathal
Journal:  J Clin Pathol       Date:  2006-06-14       Impact factor: 3.411

Review 6.  Epithelia: lymphocyte interactions in the gut.

Authors:  Stephanie Dahan; Franziska Roth-Walter; Paul Arnaboldi; Shradha Agarwal; Lloyd Mayer
Journal:  Immunol Rev       Date:  2007-02       Impact factor: 12.988

7.  CD74 Deficiency Mitigates Systemic Lupus Erythematosus-like Autoimmunity and Pathological Findings in Mice.

Authors:  Yi Zhou; Huimei Chen; Li Liu; Xueqing Yu; Galina K Sukhova; Min Yang; Lijun Zhang; Vasileios C Kyttaris; George C Tsokos; Isaac E Stillman; Takaharu Ichimura; Joseph V Bonventre; Peter Libby; Guo-Ping Shi
Journal:  J Immunol       Date:  2017-02-20       Impact factor: 5.422

Review 8.  Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy.

Authors:  M-I Torres; A Rios
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

Review 9.  CD95 (Fas/APO-1)/CD95L in the gastrointestinal tract: fictions and facts.

Authors:  J Sträter; P Möller
Journal:  Virchows Arch       Date:  2003-02-11       Impact factor: 4.064

Review 10.  Immune-epithelial crosstalk at the intestinal surface.

Authors:  Nadine Wittkopf; Markus F Neurath; Christoph Becker
Journal:  J Gastroenterol       Date:  2014-01-28       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.